Circ_0007386 Promotes the Progression of Hepatocellular Carcinoma Through the miR-507/ CCNT2 Axis

References

• Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18(4):223–238. doi:10.1038/s41575-020-00381-6
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Armakola M, Higgins MJ, Figley MD, et al. Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models. Nat Genet. 2012;44(12):1302–1309. doi:10.1038/ng.2434
   PubMed Web of Science ®Google Scholar
• Zheng Q, Bao C, Guo W, et al. Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. Nat Commun. 2016;7(1):11215. doi:10.1038/ncomms11215
   PubMed Web of Science ®Google Scholar
• Chen R, Wang SK, Belk JA, et al. Engineering circular RNA for enhanced protein production. Nat Biotechnol. 2023;41(2):262–272. doi:10.1038/s41587-022-01393-0
   PubMed Web of Science ®Google Scholar
• Xue C, Li G, Zheng Q, et al. The functional roles of the circRNA/Wnt axis in cancer. Mol Cancer. 2022;21(1):108. doi:10.1186/s12943-022-01582-0
   PubMed Web of Science ®Google Scholar
• Lei M, Zheng G, Ning Q, Zheng J, Dong D. Translation and functional roles of circular RNAs in human cancer. Mol Cancer. 2020;19(1):30. doi:10.1186/s12943-020-1135-7
   PubMed Web of Science ®Google Scholar
• Wang J, Zhao X, Wang Y, et al. circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma. Cell Death Dis. 2020;11(1):32. doi:10.1038/s41419-020-2230-9
   PubMed Web of Science ®Google Scholar
• Hong X, Liu N, Liang Y, et al. Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1. Mol Cancer. 2020;19(1):33. doi:10.1186/s12943-020-01149-x
   PubMed Web of Science ®Google Scholar
• Du Y, Liu X, Zhang S, et al. CircCRIM1 promotes ovarian cancer progression by working as ceRNAs of CRIM1 and targeting miR-383-5p/ZEB2 axis. Reprod Biol Endocrinol. 2021;19(1):176. doi:10.1186/s12958-021-00857-3
   PubMed Web of Science ®Google Scholar
• Yu XY, Ma CQ, Sheng YH. circRNA CRIM1 regulates the migration and invasion of bladder cancer by targeting miR182/Foxo3a axis. Clin Transl Oncol. 2022;24(6):1195–1203. doi:10.1007/s12094-021-02768-6
   PubMed Web of Science ®Google Scholar
• Ji Y, Yang S, Yan X, et al. CircCRIM1 promotes hepatocellular carcinoma proliferation and angiogenesis by sponging miR-378a-3p and regulating SKP2 expression. Front Cell Dev Biol. 2021;9:796686. doi:10.3389/fcell.2021.796686
   PubMed Web of Science ®Google Scholar
• Shang A, Gu C, Wang W, et al. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis. Mol Cancer. 2020;19(1):117. doi:10.1186/s12943-020-01235-0
   PubMed Web of Science ®Google Scholar
• Cen J, Liang Y, Huang Y, et al. Circular RNA circSDHC serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3/E2F1 axis. Mol Cancer. 2021;20(1):19. doi:10.1186/s12943-021-01314-w
   PubMed Web of Science ®Google Scholar
• Zhou Y, Mao X, Peng R, Bai D. CircRNAs in hepatocellular carcinoma: characteristic, functions and clinical significance. Int J Med Sci. 2022;19(14):2033–2043. doi:10.7150/ijms.74713
   PubMed Web of Science ®Google Scholar
• Xiong D, He R, Dang Y, et al. The latest overview of circRNA in the progression, diagnosis, prognosis, treatment, and drug resistance of hepatocellular carcinoma. Front Oncol. 2020;10:608257. doi:10.3389/fonc.2020.608257
   PubMed Web of Science ®Google Scholar
• Huang XY, Zhang P-F, Wei C-Y, et al. Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis. Mol Cancer. 2020;19(1):92. doi:10.1186/s12943-020-01213-6
   PubMed Web of Science ®Google Scholar
• Fu Y, Mackowiak B, Feng D, et al. MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression. Gut. 2023;72(10):1942–1958. doi:10.1136/gutjnl-2022-327924
   PubMed Web of Science ®Google Scholar
• Peng W, Ye L, Xue Q, et al. Silencing of circCRIM1 Drives IGF2BP1-Mediated NSCLC Immune Evasion. Cells. 2023;12(2):273. doi:10.3390/cells12020273
   PubMed Web of Science ®Google Scholar
• Patop IL, Wüst S, Kadener S. Past, present, and future of circRNAs. EMBO j. 2019;38(16):e100836. doi:10.15252/embj.2018100836
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Jakobsen T, Hager H, Kjems J. The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol. 2022;19(3):188–206. doi:10.1038/s41571-021-00585-y
   PubMed Web of Science ®Google Scholar
• Zhou WY, Cai Z-R, Liu J, et al. Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer. 2020;19(1):172. doi:10.1186/s12943-020-01286-3
   PubMed Web of Science ®Google Scholar
• Xue Q, Huang Y, Chang J, et al. CircRNA-mediated ceRNA mechanism in Osteoarthritis: special emphasis on circRNAs in exosomes and the crosstalk of circRNAs and RNA methylation. Biochem Pharmacol. 2023;212:115580. doi:10.1016/j.bcp.2023.115580
   PubMed Web of Science ®Google Scholar
• Cheng Z, Yu C, Cui S, et al. circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1. Nat Commun. 2019;10(1):3200. doi:10.1038/s41467-019-11162-4
   PubMed Web of Science ®Google Scholar
• Zhou J, Wang L, Sun Q, et al. Hsa_circ_0001666 suppresses the progression of colorectal cancer through the miR-576-5p/PCDH10 axis. Clin Transl Med. 2021;11(11):e565. doi:10.1002/ctm2.565
   PubMed Web of Science ®Google Scholar
• Li J, Zhu Z, Li S, et al. Circ_0089823 reinforces malignant behaviors of non-small cell lung cancer by acting as a sponge for microRNAs targeting SOX4(). Neoplasia. 2021;23(9):887–897. doi:10.1016/j.neo.2021.06.011
   PubMed Web of Science ®Google Scholar
• Fang X, Pan A. MiR-507 inhibits the progression of gastric carcinoma via targeting CBX4-mediated activation of Wnt/β-catenin and HIF-1α pathways. Clin Transl Oncol. 2022;24(10):2021–2028. doi:10.1007/s12094-022-02862-3
   PubMed Web of Science ®Google Scholar
• Jia L, Liu W, Cao B, Li H, Yin C. MiR-507 inhibits the migration and invasion of human breast cancer cells through Flt-1 suppression. Oncotarget. 2016;7(24):36743–36754. doi:10.18632/oncotarget.9163
   PubMedGoogle Scholar
• Zhao D, Hou Y. Long non-coding RNA nuclear-enriched abundant transcript 1 (LncRNA NEAT1) upregulates Cyclin T2 (CCNT2) in laryngeal papilloma through sponging miR-577/miR-1224-5p and blocking cell apoptosis. Bioengineered. 2022;13(1):1828–1837. doi:10.1080/21655979.2021.2017653
   PubMed Web of Science ®Google Scholar
• Meng H, Li R, Xie Y, et al. Nanoparticles Mediated circROBO1 Silencing to Inhibit Hepatocellular Carcinoma Progression by Modulating miR-130a-5p/CCNT2 Axis. Int J Nanomed. 2023;18:1677–1693. doi:10.2147/ijn.S399318
   PubMed Web of Science ®Google Scholar
• Hao X, Zhang Y, Shi X, et al. CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ. J Exp Clin Cancer Res. 2022;41(1):281. doi:10.1186/s13046-022-02494-z
   PubMed Web of Science ®Google Scholar
• Liu D, Liu W, Chen X, et al. circKCNN2 suppresses the recurrence of hepatocellular carcinoma at least partially via regulating miR-520c-3p/methyl-DNA-binding domain protein 2 axis. Clin Transl Med. 2022;12(1):e662. doi:10.1002/ctm2.662
   PubMed Web of Science ®Google Scholar
• Zhang P, Sun H, Wen P, et al. circRNA circMED27 acts as a prognostic factor and mediator to promote lenvatinib resistance of hepatocellular carcinoma. Mol Ther Nucleic Acids. 2022;27:293–303. doi:10.1016/j.omtn.2021.12.001
   PubMedGoogle Scholar
• Yamamoto S, Inoue J, Kawano T, et al. The impact of miRNA-based molecular diagnostics and treatment of NRF2-stabilized tumors. Mol Cancer Res. 2014;12(1):58–68. doi:10.1158/1541-7786.Mcr-13-0246-t
   PubMed Web of Science ®Google Scholar
• Xu L, Zhang S, Feng J, et al. ncRNAs-mediated overexpression of STIL predict unfavorable prognosis and correlated with the efficacy of immunotherapy of hepatocellular carcinoma. Cancer Cell Int. 2023;23(1):44. doi:10.1186/s12935-023-02869-y
   PubMed Web of Science ®Google Scholar